CWM LLC boosted its holdings in CME Group Inc (NASDAQ:CME) by 8.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,692 shares of the financial services provider’s stock after buying an additional 132 shares during the period. CWM LLC’s holdings in CME Group were worth $328,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also modified their holdings of CME. Ropes Wealth Advisors LLC increased its holdings in shares of CME Group by 3.0% during the second quarter. Ropes Wealth Advisors LLC now owns 6,674 shares of the financial services provider’s stock worth $1,295,000 after buying an additional 196 shares in the last quarter. Municipal Employees Retirement System of Michigan boosted its stake in CME Group by 2.5% in the second quarter. Municipal Employees Retirement System of Michigan now owns 4,960 shares of the financial services provider’s stock worth $963,000 after purchasing an additional 120 shares in the last quarter. Aperio Group LLC boosted its stake in CME Group by 3.7% in the second quarter. Aperio Group LLC now owns 210,967 shares of the financial services provider’s stock worth $40,951,000 after purchasing an additional 7,573 shares in the last quarter. AGF Investments LLC grew its holdings in shares of CME Group by 107.4% during the second quarter. AGF Investments LLC now owns 2,582 shares of the financial services provider’s stock worth $501,000 after purchasing an additional 1,337 shares during the last quarter. Finally, Ibex Wealth Advisors bought a new stake in shares of CME Group during the second quarter worth $152,000. 84.99% of the stock is currently owned by institutional investors.
In related news, insider Derek Sammann sold 6,400 shares of the company’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $198.83, for a total value of $1,272,512.00. Following the completion of the sale, the insider now owns 25,177 shares in the company, valued at $5,005,942.91. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction dated Tuesday, July 9th. The shares were sold at an average price of $201.30, for a total value of $503,250.00. Following the completion of the transaction, the chief financial officer now directly owns 32,854 shares in the company, valued at approximately $6,613,510.20. The disclosure for this sale can be found here. Insiders have sold a total of 58,826 shares of company stock valued at $11,921,910 in the last quarter. Corporate insiders own 1.20% of the company’s stock.
A number of research analysts recently issued reports on the company. UBS Group lifted their price target on CME Group from $191.00 to $214.00 and gave the company a “neutral” rating in a report on Thursday, September 5th. Deutsche Bank increased their price objective on shares of CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a report on Friday, August 9th. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 9th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 target price on the stock. in a research report on Monday, May 27th. Finally, Barclays increased their price target on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research note on Thursday, May 23rd. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and eight have given a buy rating to the company’s stock. CME Group currently has an average rating of “Hold” and a consensus price target of $196.85.
Shares of NASDAQ:CME opened at $215.58 on Tuesday. The stock has a market capitalization of $79.20 billion, a P/E ratio of 31.61, a P/E/G ratio of 4.93 and a beta of 0.19. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.15. CME Group Inc has a 1-year low of $161.05 and a 1-year high of $224.91. The business has a 50-day moving average price of $211.18 and a two-hundred day moving average price of $190.75.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the previous year, the firm posted $1.74 earnings per share. CME Group’s revenue for the quarter was up 20.1% compared to the same quarter last year. As a group, equities analysts predict that CME Group Inc will post 6.69 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.39%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio is presently 43.99%.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Recommended Story: What is the definition of market timing?
Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.